Protease Inhibitor vs. Raltegravir-based ART and Inflammation in HIV Infection
Condition(s):HIVLast Updated:March 21, 2023Completed
Hide Studies Not Open or Pending
Condition(s):HIVLast Updated:March 21, 2023Completed
Condition(s):HIV InfectionsLast Updated:September 13, 2023Completed
Condition(s):HIV InfectionsLast Updated:November 13, 2023Completed
Condition(s):HIV; HIV-1; Human Immunodeficiency VirusLast Updated:July 29, 2008Completed
Condition(s):HIV InfectionsLast Updated:December 22, 2023Recruiting
Condition(s):HIV InfectionsLast Updated:April 27, 2012Withdrawn
Condition(s):HIV-1; HIV InfectionsLast Updated:February 1, 2013Completed
Condition(s):HIV InfectionsLast Updated:January 15, 2019Completed
Condition(s):Infection, Human Immunodeficiency Virus; HIV InfectionsLast Updated:March 15, 2022Completed
Condition(s):HIV InfectionsLast Updated:July 22, 2011Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.